Literature DB >> 10956313

Left ventricular dysfunction: causes, natural history, and hopes for reversal.

P W Armstrong1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10956313      PMCID： PMC1766527          DOI： 10.1136/heart.84.suppl_1.i15

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  7 in total

1.  Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction.

Authors:  N Sharpe; J Murphy; H Smith; S Hannan
Journal:  Lancet       Date:  1988-02-06       Impact factor: 79.321

Review 2.  Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.

Authors:  E M Lonn; S Yusuf; P Jha; T J Montague; K K Teo; C R Benedict; B Pitt
Journal:  Circulation       Date:  1994-10       Impact factor: 29.690

3.  Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations.

Authors:  K E Hammermeister; T A DeRouen; H T Dodge
Journal:  Circulation       Date:  1979-03       Impact factor: 29.690

4.  Changing epidemiological features of cardiac failure.

Authors:  W B Kannel; K Ho; T Thom
Journal:  Br Heart J       Date:  1994-08

5.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors:  M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

6.  ACE inhibitor co-therapy in patients with heart failure: rationale for the Randomized Aldactone Evaluation Study (RALES).

Authors:  D Pitt
Journal:  Eur Heart J       Date:  1995-12       Impact factor: 29.983

Review 7.  Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.

Authors:  K T Weber; C G Brilla
Journal:  Circulation       Date:  1991-06       Impact factor: 29.690
  7 in total
  10 in total

1.  A Mediterranean-style diet, its components and the risk of heart failure: a prospective population-based study in a non-Mediterranean country.

Authors:  J Wirth; R di Giuseppe; H Boeing; C Weikert
Journal:  Eur J Clin Nutr       Date:  2016-08-10       Impact factor: 4.016

2.  Association of natriuretic peptide polymorphisms with left ventricular dysfunction in southern Han Chinese coronary artery disease patients.

Authors:  Zhijun Wu; Min Xu; Haihui Sheng; Yuqing Lou; Xiuxiu Su; Yanjia Chen; Lin Lu; Yan Liu; Wei Jin
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

3.  Passive Self Resonant Skin Patch Sensor to Monitor Cardiac Intraventricular Stroke Volume Using Electromagnetic Properties of Blood.

Authors:  Fayez Alruwaili; Kim Cluff; Jacob Griffith; Hussam Farhoud
Journal:  IEEE J Transl Eng Health Med       Date:  2018-09-26       Impact factor: 3.316

4.  Role of angiotensin II type I (AT1 A1166C) receptor polymorphism in susceptibility of left ventricular dysfunction.

Authors:  Avshesh Mishra; Anshika Srivastava; Surendra Kumar; Tulika Mittal; Naveen Garg; Surendra Kumar Agarwal; Shantanu Pande; Balraj Mittal
Journal:  Indian Heart J       Date:  2015-05-07

5.  Comprehensive Characterization of Swine Cardiac Troponin T Proteoforms by Top-Down Mass Spectrometry.

Authors:  Ziqing Lin; Fang Guo; Zachery R Gregorich; Ruixiang Sun; Han Zhang; Yang Hu; Dhanansayan Shanmuganayagam; Ying Ge
Journal:  J Am Soc Mass Spectrom       Date:  2018-04-09       Impact factor: 3.109

6.  Left ventricular dilation and incident congestive heart failure in asymptomatic adults without cardiovascular disease: multi-ethnic study of atherosclerosis (MESA).

Authors:  Joseph Yeboah; David A Bluemke; W Gregory Hundley; Carlos J Rodriguez; Joao A C Lima; David M Herrington
Journal:  J Card Fail       Date:  2014-09-16       Impact factor: 5.712

7.  Progression of Left Ventricular Dysfunction and Remodelling under Optimal Medical Therapy in CHF Patients: Role of Individual Genetic Background.

Authors:  Marzia Rigolli; Mariantonietta Cicoira; Corinna Bergamini; Andrea Chiampan; Andrea Rossi; Corrado Vassanelli
Journal:  Cardiol Res Pract       Date:  2011-01-05       Impact factor: 1.866

8.  Interleukin-2 and Interferon-Gamma Single Nucleotide Polymorphisms in Iranian Patients with Chronic Heart Failure.

Authors:  Mohammad Jafar Mahmoudi; Sara Harsini; Elham Farhadi; Mona Hedayat; Mohammad Taghvaei; Maryam Mahmoudi; Maryam Sadr; Nilufar Esfahanian; Ebrahim Nematipour; Keramat Nourijelyani; Ali Akbar Amirzargar; Nima Rezaei
Journal:  Avicenna J Med Biotechnol       Date:  2018 Jul-Sep

9.  Co-construction of health technology assessment recommendations with patients: An example with cardiac defibrillator replacement.

Authors:  Marie-Pascale Pomey; Philippe Brouillard; Isabelle Ganache; Laurie Lambert; Lucy Boothroyd; Caroline Collette; Sylvain Bédard; Alexandre Grégoire; Sandra Pelaez; Olivier Demers-Payette; Mireille Goetghebeur; Michèle de Guise; Denis Roy
Journal:  Health Expect       Date:  2019-11-05       Impact factor: 3.377

Review 10.  Engineering the Cellular Microenvironment of Post-infarct Myocardium on a Chip.

Authors:  Natalie N Khalil; Megan L McCain
Journal:  Front Cardiovasc Med       Date:  2021-07-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.